Professional Documents
Culture Documents
Causes
Decreased excretion: hypoparathyroidism, acute or chronic renal failure, volume depletion.
Increased intake: vitamin D excess with increased GI absorption, fertilizer poisoning, excess
administration of phosphorus supplements, excess use of Phosphorus containing laxatives or
enemas
Extracellular shifts: respiratory acidosis and metabolic acidosis, diabetic ketoacidosis, infection
Movement of phosphorus out of cells: Neoplastic disease (leukemia, lymphoma), increased
tissue catabolism (trauma, crush injury), tumor lysis syndrome, chemotherapy, rhabdomyolysis
(breakdown of striated muscle)
Most symptoms associated with hyperphosphatemia are actually associated with the accompanying
hypocalcemia that often occurs. Other symptoms may occur in metastatic disease due to soft tissue
calcification: corneal haziness, conjunctivitis, oliguria, irregular HR, and papular eruptions.
Lab Tests
Blood urea nitrogen (BUN): assess renal status
Creatinine: assess renal status
Imaging: assess bone density: osteodystrophy
Parathyroid hormone: decreased – identify hyperparathyroidism
Serum calcium: help identify primary cause
Serum phosphorus: increased
Treatment: Medications
Treat underlying cause: correct volume depletion, treat secondary hyperparathyroidism in chronic
renal failure: in chronic renal failure excess PTH can lead to elevated phosphorus and bone disease.
Vitamin D can help reduce PTH levels.
Phosphate binders: (Renvela) Phosphate binders bind to Phosphorus in the GI tract to decrease
absorption.
Antacids to bind phosphorus (Aluminum, Calcium, or Magnesium antacids): These medications will
bind to phosphorus and decrease absorption. In renal failure Calcium is preferred to Magnesium or
Aluminum.